Phase II study of rituximab given in conjunction with standard chemotherapy in primary central nervous system lymphoma (PCNSL): A trial of the ECOG-ACRIN cancer research group (E1F05)

Lode J. Swinnen, Anne O'Neill, Philip H. Imus, Sachin Gujar, David Schiff, Lawrence R. Kleinberg, Ranjana H. Advani, Erin M. Dunbar, Dennis Moore, Stuart A. Grossman

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of rituximab given in conjunction with standard chemotherapy in primary central nervous system lymphoma (PCNSL): A trial of the ECOG-ACRIN cancer research group (E1F05)'. Together they form a unique fingerprint.

Medicine & Life Sciences